Atrás
Rango del Día
$6.90
$7.29
Rango de 52 Semanas
$6.11
$11.78
Volumen
149,362
Promedio 50D / 200D
$7.92
/
$7.75
Cierre Anterior
$6.72
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 127.3 | 0.4 |
| P/B | 6.0 | 2.9 |
| ROE % | 5.9 | 3.8 |
| Net Margin % | 4.3 | 3.9 |
| Rev Growth 5Y % | 99.7 | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$16.00
+127.3%
EPS Futuro
-$0.32
Ingresos Est.
140 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$0.25
$0.21 – $0.31
|
310 M | 1 |
| FY2029 |
$0.11
$0.09 – $0.14
|
270 M | 1 |
| FY2028 |
$1.71
$1.42 – $2.12
|
440 M | 1 |
Puntos Clave
Revenue grew 99.65% annually over 5 years — strong growth
Earnings declined -58.40% over the past year
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -180,000.0
P/E of 127.29 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 89.41%
Crecimiento
Revenue Growth (5Y)
99.65%
Revenue (1Y)10.24%
Earnings (1Y)-58.40%
FCF Growth (3Y)N/A
Calidad
Return on Equity
5.94%
ROIC8.05%
Net Margin4.31%
Op. Margin9.85%
Seguridad
Debt / Equity
0.01
Current Ratio5.60
Interest Coverage0.00
Valoración
P/E Ratio
127.29
P/B Ratio6.03
EV/EBITDA52.56
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 10.24% | Revenue Growth (3Y) | 1.37% |
| Earnings Growth (1Y) | -58.40% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 99.65% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 116.59M | Net Income (TTM) | 5.03M |
| ROE | 5.94% | ROA | 3.03% |
| Gross Margin | 95.35% | Operating Margin | 9.85% |
| Net Margin | 4.31% | Free Cash Flow (TTM) | -180,000.0 |
| ROIC | 8.05% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 5.60 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 127.29 | P/B Ratio | 6.03 |
| P/S Ratio | 5.49 | PEG Ratio | -2.10 |
| EV/EBITDA | 52.56 | Dividend Yield | 0.00% |
| Market Cap | 639.87M | Enterprise Value | 603.74M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 116.59M | 105.76M | 113.45M | 102.29M | 7.34M |
| Net Income | 5.03M | 12.09M | -92.93M | 2.30M | -87.93M |
| EPS (Diluted) | 0.02 | 0.05 | -1.41 | 0.03 | -2.87 |
| Gross Profit | 111.17M | 101.87M | 108.81M | 97.50M | -332,000.0 |
| Operating Income | 11.49M | 16.16M | -67.23M | 9.20M | -83.73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 166.13M | 125.41M | 116.54M | 84.75M | 55.66M |
| Total Liabilities | 23.85M | 27.00M | 102.59M | 12.54M | 14.57M |
| Shareholders' Equity | 106.03M | 63.32M | -15.83M | 42.52M | 41.09M |
| Total Debt | 939,000.0 | 1.60M | 409,000.0 | 613,000.0 | 2.39M |
| Cash & Equivalents | 37.07M | 11.81M | 33.51M | 25.18M | 44.35M |
| Current Assets | 102.37M | 64.79M | 57.22M | 49.65M | 51.48M |
| Current Liabilities | 18.29M | 19.52M | 20.05M | 12.24M | 14.17M |